Skip to main content

Imbruvica Prices, Coupons and Patient Assistance Programs

Imbruvica (ibrutinib) is a member of the BTK inhibitors drug class and is commonly used for Chronic Lymphocytic Leukemia, Graft-versus-host disease, Lymphoma, and others.

The cost for Imbruvica oral capsule 140 mg is around $17,929 for a supply of 90 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Imbruvica is available as a brand name drug only, a generic version is not yet available. View generic Imbruvica availability for more details.

Imbruvica prices

Oral Capsule

Oral Suspension

Oral Tablet

Imbruvica Coupons, Copay Cards and Rebates

Imbruvica offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Imbruvica Copay Card

Eligible commercially insured patients may pay no more than $0 per prescription; for additional information contact the program at 888-968-7743.

Applies to:
Number of uses:
Per prescription until program expires

Form more information phone: 888-968-7743 or Visit website

Patient Assistance & Copay Programs for Imbruvica

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program

Eligibility requirements:
  1. Contact program for details.
  2. Varies. *See below for details
  3. Medication must be for outpatient use only
  4. The patient must also be permanently residing in the US or US territories.
  5. *Please call (800) 652-6227 or visit Program website for specific FPL income requirements.
Applicable drugs:
  • Imbruvica (ibrutinib) Capsule
  • Imbruvica (ibrutinib) Oral Suspension
  • Imbruvica (ibrutinib) Tablet

More information please phone: 800-652-6227 Visit Website

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Imbruvica (ibrutinib) Capsule

More information please phone: 866-316-7263 Visit Website

Provider: HealthWell Foundation Copay Program

Eligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
  • Imbruvica (ibrutinib)

More information please phone: 800-675-8416 Visit Website